Enzymatic ␣2,3-sialylation of GalNAc has not been described previously, although some glycoconjugates containing ␣2,3-sialylated GalNAc residues have been reported. In the present experiments, recombinant soluble ␣2,3-sialyltransferase ST3Gal II efficiently sialylated the X 2 pentasaccharide GalNAc1-3Gal1-4GlcNAc1-3Gal1-4Glc, globo-N-tetraose GalNAc1-3Gal␣1-4Gal1-4Glc, and the disaccharide GalNAc1-3Gal in vitro. The purified products were identified as Neu5Ac␣2-3GalNAc1-3Gal1-4GlcNAc1-3Gal1-4Glc, Neu5Ac␣2-3GalNAc1-3Gal␣1-4Gal1-4Glc, and Neu5Ac␣2-3GalNAc1-3Gal, respectively, by matrixassisted laser desorption/ionization time-of-flight mass spectrometry, enzymatic degradations, and oneand two-dimensional NMR-spectroscopy. In particular, the presence of the Neu5Ac␣2-3GalNAc linkage was firmly established in all three products by a long range correlation between Neu5Ac C2 and GalNAc H3 in heteronuclear multiple bond correlation spectra. Collectively, the data describe the first successful sialyltransfer reactions to the 3-position of GalNAc in any acceptor. Previously, ST3Gal II has been shown to transfer to the Gal1-3GalNAc determinant. Consequently, the present data show that the enzyme is multifunctional, and could be renamed ST3Gal(NAc) II. In contrast to ST3Gal II, ST3Gal III did not transfer to the X 2 pentasaccharide. The Neu5Ac␣2-3GalNAc linkage of sialyl X 2 was cleaved by sialidases from Arthrobacter ureafaciens and Clostridium perfringens, but resisted the action of sialidases from Newcastle disease virus and Streptococcus pneumoniae. Therefore, the latter two enzymes cannot be used to differentiate between Neu5Ac␣2-3GalNAc and Neu5Ac␣2-6GalNAc linkages, as has been assumed previously.Enzymatic ␣2,3-sialylation of GalNAc 1 has not been described before, although structures containing ␣2,3-sialylated GalNAc residues, like sialyl X 2 , have been reported. The X 2 epitope, GalNAc1-3Gal1-4GlcNAc1-3Gal1-4Glc, and its distally ␣2,3-sialylated form have been characterized from glycosphingolipids on human red blood cells (1-3). Immunohistochemical experiments with the anti-X 2 monoclonal antibody TH2 suggest the presence of X 2 and sialylated X 2 also in human white blood cells, liver, spleen, lung, kidney, colon, pancreas, brain, and placenta (3). High concentration of X 2 glycolipid has been reported in gastric tumor tissue (4). Sialyl globoside (Neu5Ac␣2-3GalNAc1-3Gal␣1-4Gal1-4Glc) has been characterized from human teratocarcinoma cells (5) and from muscles affected by amyotrophic lateral sclerosis (6) by chromatographic behavior, exoglycosidase treatments, and antibody reactivity. Additionally, sialyl LacdiNAc (Neu5Ac␣2-3GalNAc1-4GlcNAc) from snake venom serine proteases contains ␣2,3-sialylated GalNAc (7, 8). It has been suggested that the X 2 epitope is the human receptor for Clostridium difficile toxin A (9). The X 2 structure also occurs in the lipooligosaccharide of Neisseria gonorrhoeae strain F62 (10).The known mammalian ␣2,3-sialyltransferases, ST3Gal I-VI, 2 transfer sialic acid...